Ocular Therapeutix, Inc. (OCUL)
6.96
-0.33
(-4.53%)
USD |
NASDAQ |
Oct 02, 16:00
6.98
+0.02
(+0.29%)
After-Hours: 20:00
Ocular Therapeutix Price to Book Value : 2.939 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.939 |
| October 01, 2026 | 3.078 |
| September 30, 2026 | 3.239 |
| September 29, 2026 | 3.323 |
| September 28, 2026 | 3.232 |
| September 25, 2026 | 4.075 |
| September 24, 2026 | 4.146 |
| September 23, 2026 | 4.222 |
| September 22, 2026 | 4.434 |
| September 21, 2026 | 4.218 |
| September 18, 2026 | 4.218 |
| September 17, 2026 | 4.282 |
| September 16, 2026 | 4.168 |
| September 15, 2026 | 4.303 |
| September 14, 2026 | 4.527 |
| September 11, 2026 | 4.429 |
| September 10, 2026 | 4.484 |
| September 09, 2026 | 4.843 |
| September 08, 2026 | 4.801 |
| September 04, 2026 | 4.493 |
| September 03, 2026 | 4.493 |
| September 02, 2026 | 4.603 |
| September 01, 2026 | 4.463 |
| August 31, 2026 | 4.429 |
| August 28, 2026 | 4.375 |
| Date | Value |
|---|---|
| August 27, 2026 | 4.569 |
| August 26, 2026 | 4.548 |
| August 25, 2026 | 4.594 |
| August 24, 2026 | 4.552 |
| August 21, 2026 | 4.679 |
| August 20, 2026 | 4.683 |
| August 19, 2026 | 4.953 |
| August 18, 2026 | 4.649 |
| August 17, 2026 | 4.497 |
| August 14, 2026 | 4.239 |
| August 13, 2026 | 4.265 |
| August 12, 2026 | 4.320 |
| August 11, 2026 | 4.121 |
| August 10, 2026 | 3.902 |
| August 07, 2026 | 3.880 |
| August 06, 2026 | 3.690 |
| August 05, 2026 | 3.589 |
| August 04, 2026 | 3.627 |
| August 03, 2026 | 3.547 |
| July 31, 2026 | 3.450 |
| July 30, 2026 | 3.576 |
| July 29, 2026 | 3.53 |
| July 28, 2026 | 3.568 |
| July 27, 2026 | 3.648 |
| July 24, 2026 | 3.591 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| EyePoint, Inc. | 1.660 |
| ANI Pharmaceuticals, Inc. | 2.776 |
| Theravance Biopharma, Inc. | 3.050 |
| Corcept Therapeutics, Inc. | 17.77 |
| Veru, Inc. | 1.508 |
Price to Book Value Related Metrics
| PS Ratio | 28.61 |
| PEG Ratio | -0.4648 |
| Price | 6.96 |
| Earnings Yield | -20.30% |
| Market Cap | 1.528B |
| PEGY Ratio | -0.4648 |